Company intelligence / Profile preview

Xi'an Wanlong Pharmaceutical

Xi'an, Shaanxi, China

Ownership: Private
Employees: ~700
Development stage: Other

Overview

Xi'an Wanlong Pharmaceutical manufactures APIs, formulations, and intermediates, exporting both finished drugs and raw materials globally. The company holds GMP and DMF certifications and produces drugs for infections, diabetes complications, anesthesia, hypertension, and more. Clinical activities include bioequivalence and formulation studies for generics and finished dosage forms. Recent clinical studies include bioequivalence for bestatin capsules.

Therapeutic areas: EndocrinologyPsychiatryInfectious DiseasesCardiovascularOther
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Jilin Pharmaceutical Industry Design Institute

Beyond the preview

Go deeper on Xi'an Wanlong Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xi'an Wanlong Pharmaceutical.

Explore the full profile